Skip to main content
Clinical Trials/NCT00921141
NCT00921141
Completed
Not Applicable

Assessment of Complications, Quality of Life and Easiness of Use of Implantable Central Venous Access Ports : Cohort and Prospective Study

Centre Oscar Lambret1 site in 1 country815 target enrollmentMay 2006
ConditionsCancer

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cancer
Sponsor
Centre Oscar Lambret
Enrollment
815
Locations
1
Primary Endpoint
Incidence and collection of complications for the patients requiring an implantable central venous access ports substitution/change
Status
Completed
Last Updated
13 years ago

Overview

Brief Summary

This is a prospective, descriptive and observational study of the anticancer center practice

Registry
clinicaltrials.gov
Start Date
May 2006
End Date
April 2009
Last Updated
13 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patient with any cancer, requiring a central venous catheter
  • No contraindication for any surgery with local or complete anaesthesia

Exclusion Criteria

  • Previous Xylocaine or Lidocaine allergy
  • Clinic superior vena cava syndrome

Outcomes

Primary Outcomes

Incidence and collection of complications for the patients requiring an implantable central venous access ports substitution/change

Time Frame: Until the implantable central venous access ports removal

Secondary Outcomes

  • Brief description of the different risk factor for morbidity(Until the implantable central venous access ports removal)
  • Assessment of the implantable central venous access ports ease-of-use for nurses according to the modalities of implementation and patient features(Until the implantable central venous access ports removal)
  • Assessment of the patient quality of life(Before central venous access ports implementation, at the first day of chemotherapy, and during the cycle 4 of chemotherapy)

Study Sites (1)

Loading locations...

Similar Trials